Psychopharmacology of borderline personality disorder

ArticleinPsychiatric Clinics of North America 23(1):169-92, ix · April 2000with7 Reads
Impact Factor: 2.13 · DOI: 10.1016/S0193-953X(05)70150-7 · Source: PubMed

    Abstract

    Pharmacotherapy for patients with borderline personality disorder is directed against the psychobiology of cognitive-perceptual, affective, and impulsive-behavioral symptoms. A symptom-specific method using current empiric evidence for drug efficacy in each symptom domain is proposed. Drugs in each medication class have some potential utility against specific symptoms in patients with borderline personality disorder.